The Business Brew cover image

Randy Baron - International Truffle Hunting

The Business Brew

CHAPTER

Is Rhenolytics Trying to Cure Kidney Disease?

The two public companies in the space are Davida and Forzanias, maybe 20 billion in market cap between them, and they're dialysis companies. And on the other side of it is a company called Read Analytics that's basically giving the diagnostic. Bill: I've got a tire company investment. Maybe that's a derivative, more downforce on cars. Yeah, we'll do part two. But the other part of the unholy trinity that I'm known for is a stock called Rhenolytics, okay? This is a company that is trying to cure kidney disease.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner